DK354076A - Solubiliseret og stabiliseret oplosning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz (b,f) (1,4) oxazepin eller et syreadditionssalt deraf samt fremgangsmade til fremstilling af en sadan oplosning - Google Patents

Solubiliseret og stabiliseret oplosning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz (b,f) (1,4) oxazepin eller et syreadditionssalt deraf samt fremgangsmade til fremstilling af en sadan oplosning

Info

Publication number
DK354076A
DK354076A DK354076A DK354076A DK354076A DK 354076 A DK354076 A DK 354076A DK 354076 A DK354076 A DK 354076A DK 354076 A DK354076 A DK 354076A DK 354076 A DK354076 A DK 354076A
Authority
DK
Denmark
Prior art keywords
oxazepine
dibenz
solubilized
piperazinyl
chloro
Prior art date
Application number
DK354076A
Other languages
English (en)
Other versions
DK147727C (da
DK147727B (da
Inventor
B E Haeger
J E Krueger
J A Lowery
L Ritter
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK354076A publication Critical patent/DK354076A/da
Publication of DK147727B publication Critical patent/DK147727B/da
Application granted granted Critical
Publication of DK147727C publication Critical patent/DK147727C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK354076A 1975-08-06 1976-08-05 Fremgangsmaade til fremstilling af en solubiliseret og stabiliseret oploesning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepin eller et farmaceutisk acceptabelt salt deraf DK147727C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60233175A 1975-08-06 1975-08-06
US60233175 1975-08-06

Publications (3)

Publication Number Publication Date
DK354076A true DK354076A (da) 1977-02-07
DK147727B DK147727B (da) 1984-11-26
DK147727C DK147727C (da) 1985-06-17

Family

ID=24410918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK354076A DK147727C (da) 1975-08-06 1976-08-05 Fremgangsmaade til fremstilling af en solubiliseret og stabiliseret oploesning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepin eller et farmaceutisk acceptabelt salt deraf

Country Status (19)

Country Link
JP (1) JPS5221313A (da)
AR (1) AR210501A1 (da)
AT (1) AT345464B (da)
AU (1) AU500641B2 (da)
BE (1) BE844903A (da)
CA (1) CA1069823A (da)
DE (1) DE2633943A1 (da)
DK (1) DK147727C (da)
EG (1) EG12425A (da)
ES (1) ES450520A1 (da)
FI (1) FI762171A (da)
FR (1) FR2320102A1 (da)
GB (1) GB1546933A (da)
IL (1) IL49996A (da)
NL (1) NL7608575A (da)
NO (1) NO146457C (da)
PT (1) PT65400B (da)
SE (1) SE431716B (da)
ZA (1) ZA764052B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739254B1 (fr) * 1995-09-29 1997-12-19 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
WO2010106325A2 (en) 2009-03-18 2010-09-23 Omnipharm Limited Parasiticidal formulation

Also Published As

Publication number Publication date
PT65400B (en) 1978-01-27
JPS5221313A (en) 1977-02-17
DE2633943A1 (de) 1977-02-17
NO762713L (da) 1977-02-08
AT345464B (de) 1978-09-25
SE431716B (sv) 1984-02-27
NO146457B (no) 1982-06-28
ES450520A1 (es) 1978-05-01
CA1069823A (en) 1980-01-15
GB1546933A (en) 1979-05-31
AR210501A1 (es) 1977-08-15
NL7608575A (nl) 1977-02-08
FR2320102A1 (fr) 1977-03-04
IL49996A (en) 1981-01-30
IL49996A0 (en) 1976-09-30
PT65400A (en) 1976-08-01
AU500641B2 (en) 1979-05-31
EG12425A (en) 1979-06-30
ATA581376A (de) 1978-01-15
BE844903A (fr) 1977-02-07
ZA764052B (en) 1977-06-29
NO146457C (no) 1982-10-06
FI762171A (da) 1977-02-07
SE7608810L (sv) 1977-02-07
DK147727C (da) 1985-06-17
DK147727B (da) 1984-11-26
AU1577576A (en) 1978-01-12

Similar Documents

Publication Publication Date Title
KR830000388U (ko) 포켓(Pocket)이 달린 운동화
JPS5395943A (en) 3-di-o-methylfortemycins
IT8024755A0 (it) Nuovi peptidi biologicamente attivi.
NL161963B (nl) Statische neutralisator.
BR7905331A (pt) Circuito de controle de solenoide
SE7707790L (sv) Teckpappersmaterial ("lineboard composition"), jemte forfarande for dess framstellning
DK154299C (da) Analogifremgangsmaade til fremstilling af dibenzoimidazo-azepiner, -oxazepiner og -thiazepiner
IT8025711A0 (it) Circuito oscillatore controllato in fase automatico.
IT8026254A0 (it) Circuito di controllo d'orologio.
BR8004993A (pt) Circuito de controle
DK118277A (da) Fremgangsmade til fremstilling af n-5-tetrazololyl)-4-oxo-4h-pyrimido (2,1-b)benzothiazol-3-carboxamider
DK319776A (da) Farmaceutisk middel indeholdende den frie base eller pamoatsaltet af substituerede dibenz (b,f)-(1,4) oxazepiner og fremgangsmade til fremstilling deraf
NO157461C (no) Hydrogenutviklende elektrode.
DK354076A (da) Solubiliseret og stabiliseret oplosning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz (b,f) (1,4) oxazepin eller et syreadditionssalt deraf samt fremgangsmade til fremstilling af en sadan oplosning
IT8322464A0 (it) Pellicola per prove cromatiche.
DK159790C (da) Elektrode til elektrolyseceller, samt anvendelse af en saadan.
JPS5697529A (en) Automatic manufacture of solution from noxious substance on environment
BE857629A (fr) Compositions stabilisees de 1,1,1-trichloroethane
TR18837A (tr) Kaplama baski usuluene nazaran selueloz elyafinin ve selueloz elyafi ihtiva eden karma dokumalarin tab edilmesine mahsus bir usul ve buna ait yardimci tasiyicilar
NL7708128A (nl) Gyroscopisch instrument.
HK90985A (en) Stabilized hemotological reagent solution
IT8024978A0 (it) Circuito logico per utenze elettriche.
BE851591A (fr) Composition de poly (phosphazene) stabilisee
NO771437L (no) Biologisk aktivt stoff.
NL172050C (nl) Ontstekersas bevattende tetrazeen.

Legal Events

Date Code Title Description
PUP Patent expired